Unnamed: 0,title,date,stock,sentiment
234470.0,"Cancer Genetics Q1 EPS $(0.14) Up From $(0.90) YoY, Sales $1.90M Down From $6.84M YoY",2020-06-01 08:06:00-04:00,CGIX,negative
234471.0,84 Biggest Movers From Yesterday,2020-04-07 05:47:00-04:00,CGIX,neutral
234472.0,66 Stocks Moving In Monday's Mid-Day Session,2020-04-06 12:32:00-04:00,CGIX,neutral
234473.0,74 Biggest Movers From Friday,2020-04-06 04:46:00-04:00,CGIX,neutral
234474.0,Interpace Biosciences CEO Jack Stover On Diagnostics Business: 'Much Of The Growth Opportunity Is Around Awareness',2020-04-01 16:26:00-04:00,CGIX,positive
234475.0,"The Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation Company",2020-03-20 07:44:00-04:00,CGIX,negative
234476.0,90 Biggest Movers From Yesterday,2020-03-12 06:10:00-04:00,CGIX,neutral
234477.0,100 Biggest Movers From Friday,2020-03-09 05:25:00-04:00,CGIX,neutral
234478.0,95 Biggest Movers From Yesterday,2020-02-21 05:12:00-05:00,CGIX,neutral
234479.0,71 Stocks Moving In Thursday's Mid-Day Session,2020-02-20 12:16:00-05:00,CGIX,neutral
234480.0,"Cancer Genetics Pres, CEO Sends Letter To Shareholders",2020-02-20 09:06:00-05:00,CGIX,negative
234481.0,100 Biggest Movers From Yesterday,2020-02-07 04:30:00-05:00,CGIX,neutral
234482.0,146 Biotechnology Stocks Moving In Thursday's Session,2020-01-23 12:47:00-05:00,CGIX,neutral
234483.0,78 Biggest Movers From Yesterday,2019-12-24 04:32:00-05:00,CGIX,neutral
234484.0,44 Stocks Moving In Monday's Mid-Day Session,2019-12-23 12:19:00-05:00,CGIX,neutral
234485.0,74 Biggest Movers From Friday,2019-12-09 05:22:00-05:00,CGIX,neutral
234486.0,55 Stocks Moving In Friday's Mid-Day Session,2019-12-06 12:02:00-05:00,CGIX,neutral
234487.0,75 Biggest Movers From Yesterday,2019-12-06 05:36:00-05:00,CGIX,neutral
234488.0,50 Stocks Moving In Thursday's Mid-Day Session,2019-12-05 12:07:00-05:00,CGIX,neutral
234489.0,75 Biggest Movers From Yesterday,2019-12-03 05:48:00-05:00,CGIX,neutral
234490.0,44 Stocks Moving In Monday's Mid-Day Session,2019-12-02 12:11:00-05:00,CGIX,neutral
234491.0,Shares of several healthcare stocks are trading lower as US equities dip following escalating US-China tensions over Hong Kong. US Stocks further fell on worse-than-expected manufacturing data.,2019-12-02 11:31:00-05:00,CGIX,negative
234492.0,Mid-Morning Market Update: Markets Open Lower; Hostess Brands To Buy Voortman Cookies,2019-12-02 10:12:00-05:00,CGIX,negative
234493.0,18 Stocks Moving in Monday's Pre-Market Session,2019-12-02 07:17:00-05:00,CGIX,neutral
234494.0,52 Biggest Movers From Friday,2019-12-02 04:44:00-05:00,CGIX,neutral
234495.0,35 Stocks Moving In Friday's Mid-Day Session,2019-11-29 11:40:00-05:00,CGIX,neutral
234496.0,50 Biggest Movers From Friday,2019-11-25 06:30:00-05:00,CGIX,neutral
234497.0,41 Stocks Moving In Friday's Mid-Day Session,2019-11-22 13:05:00-05:00,CGIX,neutral
234498.0,66 Biggest Movers From Yesterday,2019-11-22 04:50:00-05:00,CGIX,neutral
234499.0,45 Stocks Moving In Thursday's Mid-Day Session,2019-11-21 12:11:00-05:00,CGIX,neutral
234500.0,63 Biggest Movers From Yesterday,2019-11-21 04:49:00-05:00,CGIX,neutral
234501.0,Mid-Afternoon Market Update: Dow Down 180 Points; Pinduoduo Shares Tumble After Q3 Earnings,2019-11-20 14:31:00-05:00,CGIX,positive
234502.0,38 Stocks Moving In Wednesday's Mid-Day Session,2019-11-20 12:09:00-05:00,CGIX,neutral
234503.0,Mid-Day Market Update: Crude Oil Up Over 3%; Cancer Genetics Shares Spike Higher,2019-11-20 12:05:00-05:00,CGIX,negative
234504.0,Mid-Morning Market Update: Markets Edge Lower; Target Tops Q3 Estimates,2019-11-20 10:09:00-05:00,CGIX,positive
234505.0,Cancer Genetics shares are trading higher after the company announced it has retained H.C. Wainwright to explore strategic alternatives.,2019-11-20 08:06:00-05:00,CGIX,negative
234506.0,Cancer Genetics Q3 Sales $2.07M Up From $535K YoY,2019-11-20 08:03:00-05:00,CGIX,negative
234507.0,Cancer Genetics Says Has Retained H.C. Wainwright To Explore Strategic Alternatives,2019-11-20 08:02:00-05:00,CGIX,negative
234508.0,"The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data",2019-11-20 07:25:00-05:00,CGIX,positive
234509.0,Stocks That Hit 52-Week Lows On Tuesday,2019-11-19 11:28:00-05:00,CGIX,negative
234510.0,"The Daily Biotech Pulse: Therapix To Reverse Merge With CBD Company, Crispr Gene Editing Therapy Readout",2019-11-19 07:56:00-05:00,CGIX,neutral
234511.0,72 Biggest Movers From Yesterday,2019-11-19 04:39:00-05:00,CGIX,neutral
234512.0,Stocks That Hit 52-Week Lows On Monday,2019-11-18 13:49:00-05:00,CGIX,negative
234513.0,44 Stocks Moving In Monday's Mid-Day Session,2019-11-18 12:32:00-05:00,CGIX,neutral
234514.0,66 Biggest Movers From Friday,2019-11-18 05:37:00-05:00,CGIX,neutral
234515.0,41 Stocks Moving In Friday's Mid-Day Session,2019-11-15 12:15:00-05:00,CGIX,neutral
234516.0,Stocks That Hit 52-Week Lows On Friday,2019-11-15 10:43:00-05:00,CGIX,negative
234517.0,46 Biggest Movers From Yesterday,2019-10-29 05:39:00-04:00,CGIX,neutral
234518.0,40 Stocks Moving In Monday's Mid-Day Session,2019-10-28 12:55:00-04:00,CGIX,neutral
234519.0,51 Biggest Movers From Friday,2019-10-28 05:27:00-04:00,CGIX,neutral
234520.0,Stocks That Hit 52-Week Highs On Friday,2019-10-25 12:47:00-04:00,CGIX,neutral
234521.0,19 Stocks Moving In Friday's Mid-Day Session,2019-10-25 12:47:00-04:00,CGIX,neutral
234522.0,Cancer Genetics Reports Strategic Transactions: Note Payment Received From Interpace; Settlement With NovellusDx; Restructured Note Deal With Unsecured Lender; M&A Advisory Deal With HC Wainwright,2019-10-24 16:26:00-04:00,CGIX,negative
234523.0,Cancer Genetics Announces 1-For-30 Reverse Stock Split Effective Oct. 25,2019-10-24 08:36:00-04:00,CGIX,negative
234524.0,32 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-10-18 08:34:00-04:00,CGIX,neutral
234525.0,64 Biggest Movers From Yesterday,2019-10-15 05:07:00-04:00,CGIX,neutral
234526.0,40 Stocks Moving In Monday's Mid-Day Session,2019-10-14 12:19:00-04:00,CGIX,neutral
234527.0,Cancer Genetics shares are trading lower. Not seeing any news to justify the price action.,2019-10-14 11:26:00-04:00,CGIX,negative
234528.0,28 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-10-11 08:42:00-04:00,CGIX,neutral
234529.0,13 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-10-09 07:54:00-04:00,CGIX,neutral
234530.0,Cancer Genetics shares are trading higher. Not seeing any news to justify the price action.,2019-10-08 13:53:00-04:00,CGIX,negative
234531.0,Cancer Genetics shares are trading higher. Not seeing any news to justify the price action.,2019-10-07 11:52:00-04:00,CGIX,negative
234532.0,Cancer Genetics shares are trading higher. Not seeing any news to justify the price action.,2019-10-04 11:19:00-04:00,CGIX,negative
234533.0,12 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-10-03 08:11:00-04:00,CGIX,neutral
234534.0,Cancer Genetics shars are trading lower despite no company-specific news. This could potentially be a rebound after the stock rallied approximately 50% yesterday.,2019-10-02 09:25:00-04:00,CGIX,negative
234535.0,25 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-10-02 08:54:00-04:00,CGIX,neutral
234536.0,Shares of nano-cap biotech company Cancer Genetic are trading higher after breaking through the $0.10 level.,2019-10-01 11:26:00-04:00,CGIX,negative
234537.0,18 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-09-30 08:44:00-04:00,CGIX,neutral
234538.0,18 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-09-19 08:19:00-04:00,CGIX,neutral
234539.0,32 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-09-03 08:42:00-04:00,CGIX,neutral
234540.0,18 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-08-30 08:43:00-04:00,CGIX,neutral
234541.0,23 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-08-29 08:40:00-04:00,CGIX,neutral
234542.0,"The Daily Biotech Pulse: EC Approves Roche's Tecentriq For Breast Cancer, Trevena On Track For NDA Resubmission, Edap Earnings",2019-08-29 07:38:00-04:00,CGIX,negative
234543.0,"The Daily Biotech Pulse: EC Nod For Bristol-Myers Squibb, Kyowa Kirin's Parkinson's Add-On Therapy Approved",2019-08-28 07:31:00-04:00,CGIX,positive
234544.0,"The Daily Biotech Pulse: Nuvectra Explores Strategic Options, J&J To Contend Opioid Ruling, Sesen Bio Gets New CFO",2019-08-27 07:29:00-04:00,CGIX,positive
234545.0,Stocks That Hit 52-Week Lows On Monday,2019-08-26 10:28:00-04:00,CGIX,negative
234546.0,25 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-08-21 08:48:00-04:00,CGIX,neutral
234547.0,Cancer Genetics Q2 EPS $(0.07) Up From $(0.13) YoY,2019-08-20 08:15:00-04:00,CGIX,negative
234548.0,"The Daily Biotech Pulse: Mallinkckrodt's Terlipressin, Deciphera Offering, Sellas Reboots On Earnings",2019-08-15 07:45:00-04:00,CGIX,neutral
234549.0,16 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-08-13 08:36:00-04:00,CGIX,neutral
234550.0,31 Healthcare Stocks Moving In Today's Pre-Market Session,2019-08-09 09:00:00-04:00,CGIX,neutral
234551.0,25 Healthcare Stocks Moving In Today's Pre-Market Session,2019-08-08 08:35:00-04:00,CGIX,neutral
234552.0,Stocks That Fell Through 52-Week Lows Wednesday,2019-08-07 14:22:00-04:00,CGIX,negative
234553.0,28 Healthcare Stocks Moving In Today's Pre-Market Session,2019-08-06 08:55:00-04:00,CGIX,neutral
234554.0,28 Healthcare Stocks Moving In Today's Pre-Market Session,2019-08-02 09:07:00-04:00,CGIX,neutral
234555.0,28 Healthcare Stocks Moving In Wednesday's After-Market Session,2019-08-01 04:20:00-04:00,CGIX,neutral
234556.0,"The Daily Biotech Pulse: European Cheer For Merck, Legal Victory For Coherus, Medpace Picks Up On Earnings",2019-07-30 07:00:00-04:00,CGIX,positive
234557.0,30 Healthcare Stocks Moving In Thursday's After-Market Session,2019-07-26 04:36:00-04:00,CGIX,neutral
234558.0,"The Daily Biotech Pulse: Jounce Jumps On Licensing Deal, Regulus Hit With Partial Clinical Hold, Genomic Health Added to S&P SmallCap Index",2019-07-24 07:08:00-04:00,CGIX,neutral
234559.0,List of Companies Reaching Yearly Lows Tuesday,2019-07-23 14:58:00-04:00,CGIX,neutral
234560.0,58 Biggest Movers From Yesterday,2019-07-17 04:59:00-04:00,CGIX,neutral
234561.0,Mid-Afternoon Market Update: Crude Oil Down 4%; Cancer Genetics Shares Spike Higher,2019-07-16 14:42:00-04:00,CGIX,negative
234562.0,"A Look At Benzinga Pro's Most-Searched Tickers For July 16, 2019",2019-07-16 12:44:00-04:00,CGIX,neutral
234563.0,41 Stocks Moving In Tuesday's Mid-Day Session,2019-07-16 12:10:00-04:00,CGIX,neutral
234564.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Tuesday, July 16, 2019",2019-07-16 10:25:00-04:00,CGIX,positive
234565.0,Mid-Morning Market Update: Markets Edge Lower; Goldman Sachs Tops Q2 Views,2019-07-16 10:24:00-04:00,CGIX,positive
234566.0,Cancer Genetics Inc. shares are trading higher after Interpace Diagnostics reported it purchased the Biopharma Services unit of Cancer Genetics.,2019-07-16 09:42:00-04:00,CGIX,negative
234567.0,Cancer Genetics Sharply Higher After Interpace Buys Biopharma Unit,2019-07-16 08:44:00-04:00,CGIX,negative
234568.0,30 Stocks Moving In Tuesday's Pre-Market Session,2019-07-16 08:14:00-04:00,CGIX,neutral
234569.0,"A Peek Into The Markets: US Stock Futures Edge Lower Ahead Of Citigroup, Wells Fargo Earnings",2019-07-16 07:14:00-04:00,CGIX,negative
234570.0,"11 Stocks To Watch For July 16, 2019",2019-07-16 04:54:00-04:00,CGIX,neutral
234571.0,6 Stocks Moving In Monday's After-Hours Session,2019-07-15 16:57:00-04:00,CGIX,neutral
234572.0,Cancer Genetics shares are trading higher after Interpace Diagnostics reported it purchased the Biopharma Services unit of the Cancer Genetics.,2019-07-15 16:17:00-04:00,CGIX,negative
234573.0,Interpace Diagnostics Reports Purchase Of Cancer Genetics' Biopharma Services Unit; Ampersand Capital Will Invest $27M In Interpace In 2 Tranches Of Newly Issued Convertible Preferred Stock,2019-07-15 16:12:00-04:00,CGIX,negative
234574.0,Cancer Genetics shares are trading lower after the company reported worse-than-expected Q1 sales results.,2019-05-21 12:44:00-04:00,CGIX,negative
234575.0,Cancer Genetics shares are trading higher despite the company reporting worse-than-expected Q1 sales results.,2019-05-20 17:10:00-04:00,CGIX,negative
234576.0,"Cancer Genetics Highlights 'Continued to work with Raymond James & Associates, Inc. to complete a transaction to enhance shareholder value' Over Q1",2019-05-20 17:03:00-04:00,CGIX,negative
234577.0,"Cancer Genetics Q1 EPS $(0.9) Down From $(0.16) YoY, Sales $6.8M Miss $10.77M Estimate",2019-05-20 17:01:00-04:00,CGIX,negative
234578.0,Cancer Genetics Q4 Sales $6.8M Beat $6.3M Estimate,2019-04-16 07:09:00-04:00,CGIX,negative
234579.0,Cancer Genetics FY18 EPS $(0.75) vs $(1.01) YoY,2019-04-16 06:11:00-04:00,CGIX,negative
234580.0,58 Biggest Movers From Yesterday,2019-01-30 04:53:00-05:00,CGIX,neutral
234581.0,Mid-Afternoon Market Update: Sanmina Jumps On Upbeat Earnings; Cancer Genetics Shares Slide,2019-01-29 14:49:00-05:00,CGIX,negative
234582.0,46 Stocks Moving In Tuesday's Mid-Day Session,2019-01-29 13:02:00-05:00,CGIX,neutral
234583.0,Mid-Day Market Update: Crude Oil Up 2.7%; GameStop Shares Plummet,2019-01-29 12:26:00-05:00,CGIX,negative
234584.0,Mid-Morning Market Update: Markets Mixed; Verizon Posts Mixed Q4 Results,2019-01-29 10:23:00-05:00,CGIX,neutral
234585.0,24 Stocks Moving In Tuesday's Pre-Market Session,2019-01-29 08:09:00-05:00,CGIX,neutral
234586.0,"The Daily Biotech Pulse: Big Pharma Earnings, Kiniksa Offering, FDA Decision Day For Aquestive",2019-01-29 07:25:00-05:00,CGIX,neutral
234587.0,A Peek Into The Markets: US Stock Futures Edge Lower Ahead Of Earnings,2019-01-29 06:35:00-05:00,CGIX,negative
234588.0,Cancer Genetics Prices ~15.21M Share Public Offering of Common Stock @$0.23/Share,2019-01-29 04:36:00-05:00,CGIX,negative
234589.0,"Cancer Genetics Reports Offering Of Common Shares, No Size Disclosed",2019-01-28 16:00:00-05:00,CGIX,negative
234590.0,"Insider Buys Of The Week: Cancer Genetics, Dish Network, Valvoline",2019-01-21 09:21:00-05:00,CGIX,negative
234591.0,Cancer Genetics Says Expects To Report Quarterly Sequential Revenue Growth And Operating Cost Reductions For Q4,2019-01-16 08:50:00-05:00,CGIX,negative
234592.0,Cancer Genetics Issues Letter To Shareholders,2019-01-16 08:45:00-05:00,CGIX,negative
234593.0,55 Biggest Movers From Yesterday,2019-01-11 05:45:00-05:00,CGIX,neutral
234594.0,Mid-Afternoon Market Update: Dow Rises 50 Points; Diana Containerships Shares Spike Higher,2019-01-10 14:38:00-05:00,CGIX,positive
234595.0,40 Stocks Moving In Thursday's Mid-Day Session,2019-01-10 12:44:00-05:00,CGIX,neutral
234596.0,Mid-Day Market Update: U.S. Stocks Turn Positive; Macy's Shares Plummet,2019-01-10 12:19:00-05:00,CGIX,positive
234597.0,Mid-Morning Market Update: Markets Open Lower; Bed Bath & Beyond Profit Tops Expectations,2019-01-10 10:26:00-05:00,CGIX,positive
234598.0,Cancer Genetics shares are trading lower after the company priced a 13.33 million share offering at $0.225 per share.,2019-01-10 09:12:00-05:00,CGIX,negative
234599.0,28 Stocks Moving In Thursday's Pre-Market Session,2019-01-10 08:31:00-05:00,CGIX,neutral
234600.0,"The Daily Biotech Pulse: Cancer Genetics Prices Offering, DiaMedica Delists From Canadian Exchange, Medigus CEO Quits",2019-01-10 08:27:00-05:00,CGIX,negative
234601.0,Cancer Genetic Prices 13.33M Share Offering @$0.225/Share,2019-01-10 04:02:00-05:00,CGIX,negative
234602.0,Cancer Genetics shares are trading lower after the company announced a proposed public offering of common stock.,2019-01-09 16:28:00-05:00,CGIX,negative
234603.0,"Cancer Genetics Reports Offering Of Common Stock, No Size Disclosed",2019-01-09 16:00:00-05:00,CGIX,negative
234604.0,45 Biggest Movers From Yesterday,2018-12-19 05:01:00-05:00,CGIX,neutral
234605.0,38 Stocks Moving In Tuesday's Mid-Day Session,2018-12-18 12:29:00-05:00,CGIX,neutral
234606.0,Cancer Genetics shares are trading lower on continued weakness after the company on Monday announced it has terminated its proposed merger with NovellusDx.,2018-12-18 09:14:00-05:00,CGIX,negative
234607.0,50 Biggest Movers From Yesterday,2018-12-18 06:11:00-05:00,CGIX,neutral
234608.0,Mid-Afternoon Market Update: Dow Down Over 350 Points; Sophiris Bio Shares Plummet,2018-12-17 14:43:00-05:00,CGIX,positive
234609.0,40 Stocks Moving In Monday's Mid-Day Session,2018-12-17 12:35:00-05:00,CGIX,neutral
234610.0,Mid-Day Market Update: Crude Oil Down Over 1%; Diffusion Pharmaceuticals Shares Spike Higher,2018-12-17 12:05:00-05:00,CGIX,negative
234611.0,Cancer Genetics shares are trading lower after the company terminated its proposed merger with NovellusDx.,2018-12-17 09:23:00-05:00,CGIX,negative
234612.0,Cancer Genetics Terminates Proposed Merger With NovellusDx,2018-12-17 08:01:00-05:00,CGIX,negative
234613.0,"Sophiris and Cancer Genetics Shares Halted, News Pending",2018-12-17 07:59:00-05:00,CGIX,negative
234614.0,"Cancer Genetics shares are trading up 62.2% to over $0.50 on high volume with seemingly no news. While shares have rallied sharply over the last 2 sessions, the stock had fallen more than 80% since the start of October.",2018-12-14 13:11:00-05:00,CGIX,negative
234615.0,"The Daily Biotech Pulse: Management Change At Merck, Jazz Buyback, Arrowhead Earnings",2018-12-11 08:22:00-05:00,CGIX,neutral
234616.0,"The Daily Biotech Pulse: AbbVie Halts Lung Cancer Trial, Oncomed Merges With Mereo, Momenta Offering",2018-12-06 07:56:00-05:00,CGIX,negative
234617.0,"Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 28, 2018",2018-11-29 10:59:00-05:00,CGIX,negative
234618.0,"Stocks Which Set New 52-Week Low Yesterday Tues., Nov. 27, 2018",2018-11-28 11:54:00-05:00,CGIX,negative
234619.0,"Stocks Which Set New 52-Week Low Yesterday, Mon., Nov. 26, 2018",2018-11-27 11:26:00-05:00,CGIX,negative
234620.0,"Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018",2018-11-21 08:50:00-05:00,CGIX,negative
234621.0,"The Daily Biotech Pulse: Mylan Recalls Blood Pressure Drug, Heat Biologics Offering, New Novelion CEO",2018-11-21 08:04:00-05:00,CGIX,negative
234622.0,"Stocks Which Set New 52-Week Low Yesterday, Mon., Nov. 19, 2018",2018-11-20 09:12:00-05:00,CGIX,negative
234623.0,"The Daily Biotech Pulse: Denali's Positive Results, Novartis' Substance Abuse Therapy Launch, Medtronic Earnings",2018-11-20 08:29:00-05:00,CGIX,negative
234624.0,"Cancer Genetics Q3 EPS $(0.31) Down From $(0.16) YoY, Sales $5.9M Miss $7.57M Estimate",2018-11-19 16:19:00-05:00,CGIX,negative
234625.0,"Stocks Which Set New 52-Week Lows Fri., Nov. 16, 2018",2018-11-19 10:16:00-05:00,CGIX,negative
234626.0,Cancer Genetics Names Glenn Miles CFO,2018-11-14 16:36:00-05:00,CGIX,negative
234627.0,"The Daily Biotech Pulse: Viking's Fatty Liver And Cholesterol Drug, Cyclacel Loss Narrows, Eton's Debut",2018-11-13 07:54:00-05:00,CGIX,negative
234628.0,"Stocks Which Set New 52-Week Low Friday, October 26th",2018-10-29 09:56:00-04:00,CGIX,negative
234629.0,Cancer Genetics Enters Partnership With Genecast Biotechnology To Commercialize Tissue Of OriginO Test in China,2018-10-18 09:05:00-04:00,CGIX,negative
234630.0,Cancer Genetics and Cellaria Partner on Precision Medicine Tools,2018-10-08 07:05:00-04:00,CGIX,negative
234631.0,Cancer Genetics shares are up 10.7% after the company announced a supply deal with Agilent for the manufacture of its proprietary FISH probe reagents.,2018-09-25 16:53:00-04:00,CGIX,negative
234632.0,"Cancer Genetics Wins Non-Exclusive Supply Deal With Agilent For Manufacture Of Co.'s Proprietary FISH Probe Reagents, No Terms Disclosed",2018-09-25 16:02:00-04:00,CGIX,negative
234633.0,"Cancer Genetics Shares Resume Trade, Up 22.6%",2018-09-18 09:00:00-04:00,CGIX,negative
234634.0,Cancer Genetics Shares To Resume Trade At 9 a.m. EDT,2018-09-18 08:33:00-04:00,CGIX,negative
234635.0,"UPDATE: No Further Terms Disclosed In Cancer Genetics, NovellusDx Deal",2018-09-18 08:33:00-04:00,CGIX,negative
234636.0,"UPDATE: Existing NovellusDx Holders, Including OrbiMed Israel Partners II, Pontifax, Helsinn, SICA, Windham Venture Indicated They Will Invest $10M In Added Equity As Part Of Concurrent PIPE Financing",2018-09-18 08:32:00-04:00,CGIX,neutral
234637.0,UPDATE: NovellusDx Shareholders Will Receive Stock Equal To ~49% Of Equity Of Cancer Genetics,2018-09-18 08:31:00-04:00,CGIX,negative
234638.0,Cancer Genetics To Merger With NovellusDx,2018-09-18 08:30:00-04:00,CGIX,negative
234639.0,Cancer Genetics Shares Halted News Pending,2018-09-18 08:25:00-04:00,CGIX,negative
234640.0,"The Daily Biotech Pulse: Cesca, Acer Therapeutics Rally On Earnings, Aridis Makes Its Nasdaq Debut",2018-08-14 08:23:00-04:00,CGIX,neutral
234641.0,"Cancer Genetics Q2 EPS $(0.13) Beats $(0.16) Estimate, Sales $7.036M Miss $8.3M Estimate",2018-08-14 07:33:00-04:00,CGIX,negative
234642.0,"Earnings Scheduled For August 14, 2018",2018-08-14 04:32:00-04:00,CGIX,neutral
234643.0,Cancer Genetics Q2 Earnings Preview,2018-08-13 14:33:00-04:00,CGIX,negative
234644.0,"Benzinga's Daily Biotech Pulse: Aytu Rallies On Earnings, Evolus Awaits FDA Verdict, BofA Conference Underway",2018-05-15 08:44:00-04:00,CGIX,positive
234645.0,"Cancer Genetics Q1 EPS $(0.16) Misses $(0.13) Estimate, Sales $7.667M Miss $8.2M Estimate",2018-05-15 07:03:00-04:00,CGIX,negative
234646.0,"Earnings Scheduled For May 15, 2018",2018-05-15 04:12:00-04:00,CGIX,neutral
234647.0,Cancer Genetics Announces Sale of India Operations to REPROCELL Incorporated For $1.9M,2018-04-27 08:30:00-04:00,CGIX,negative
234648.0,Cancer Genetics' Unique Tissue of Origin Test Receives Special FDA 510(k) Clearance,2018-04-16 07:30:00-04:00,CGIX,negative
234649.0,"Cancer Genetics Inc Shares Down 25.9% Following Q4 Miss, Maxim Group Downgrade To Hold",2018-04-03 12:09:00-04:00,CGIX,negative
234650.0,"Benzinga's Top Upgrades, Downgrades For April 3, 2018",2018-04-03 09:55:00-04:00,CGIX,positive
234651.0,Maxim Group Downgrades Cancer Genetics to Hold,2018-04-03 07:42:00-04:00,CGIX,negative
234652.0,A Peek Into The Markets: US Stock Futures Rise Ahead Of Auto Sales,2018-04-03 07:04:00-04:00,CGIX,neutral
234653.0,"7 Stocks To Watch For April 3, 2018",2018-04-03 04:13:00-04:00,CGIX,neutral
234654.0,Cancer Genetics Shares DOwn 33.3% In After-Hours Trading Following Q4 Miss,2018-04-02 16:56:00-04:00,CGIX,negative
234655.0,"Cancer Genetics Q4 EPS $(0.35) May Not Compare To $(0.11 ) Est., Sales $7.5M Misses $9.19 Est.",2018-04-02 16:02:00-04:00,CGIX,negative
234656.0,"Earnings Scheduled For April 2, 2018",2018-04-02 04:15:00-04:00,CGIX,neutral
234657.0,PierianDx Reports Partnership with Cancer Genetics to Provide Comprehensive Precision Oncology Testing and Workflow Solution,2018-03-14 10:42:00-04:00,CGIX,negative
234658.0,"Cancer Genetics CEO Panna Sharma To Step Down, Names John Roberts Interim CEO",2018-02-05 08:16:00-05:00,CGIX,negative
234659.0,"Cancer Genetics Highlights Complete:IO Simultaneously Assesses 27 Unique Immune Markets, Determines Optimal IO Therapies, Tracks Response, Resistance Mechanisms",2018-01-17 07:33:00-05:00,CGIX,negative
234660.0,Cancer Genetics Reports Received Non-Dilutive Funding Of $1.1M Through New Jersey Technology Business Tax Certificate Transfer Program,2017-12-28 07:02:00-05:00,CGIX,negative
234661.0,Cancer Genetics 13G Filing From Stonepine Capital Shows New 5% Stake,2017-12-21 17:25:00-05:00,CGIX,negative
234662.0,36 Stocks Moving In Tuesday's Mid-Day Session,2017-12-19 12:25:00-05:00,CGIX,neutral
234663.0,30 Stocks Moving In Tuesday's Pre-Market Session,2017-12-19 08:08:00-05:00,CGIX,neutral
234664.0,Cancer Genetics Receives New York State Approval for FDA-Approved Oncomine Dx Target Test by Thermo Fisher Scientific,2017-12-19 07:37:00-05:00,CGIX,negative
234665.0,36 Biggest Movers From Friday,2017-12-11 06:02:00-05:00,CGIX,neutral
234666.0,25 Stocks Moving In Friday's Mid-Day Session,2017-12-08 12:01:00-05:00,CGIX,neutral
234667.0,Cancer Genetics Prices 3.5M Units At $2/Unit,2017-12-08 09:00:00-05:00,CGIX,negative
234668.0,"Maxim Group Initiates Coverage On Cancer Genetics with Buy Rating, Announces $6.00 Price Target",2017-12-07 08:24:00-05:00,CGIX,negative
234669.0,"LD Micro Small Cap Conference To Host A Litany Of High-Profile Execs, Investors",2017-12-04 16:28:00-05:00,CGIX,neutral
234670.0,"Cancer Genetics Reports Q3 EPS $(0.15) vs $(0.12) Est., Sales $8M vs $7.9M Est.",2017-11-09 07:40:00-05:00,CGIX,negative
234671.0,40 Biggest Movers From Yesterday,2017-10-31 04:54:00-04:00,CGIX,neutral
234672.0,35 Stocks Moving In Monday's Mid-Day Session,2017-10-30 12:30:00-04:00,CGIX,neutral
234673.0,Cancer Genetics Shares Up 15.23%; Co. Earlier Announced Launch Of AntigenID,2017-10-30 11:50:00-04:00,CGIX,negative
234674.0,20 Stocks Moving In Wednesday's Pre-Market Session,2017-08-16 08:11:00-04:00,CGIX,neutral
234675.0,18 Biggest Mid-Day Losers For Tuesday,2017-08-15 13:31:00-04:00,CGIX,negative
234676.0,"Cancer Genetics Reports Q2 EPS $(0.16) vs. $(0.15) Est., Sales $6.6M vs. $7.97M Est.",2017-08-14 17:03:00-04:00,CGIX,negative
234677.0,"Benzinga's Top Upgrades, Downgrades For June 27, 2017",2017-06-27 09:27:00-04:00,CGIX,positive
234678.0,Dawson James Initiates Coverage On Cancer Genetics with Buy Rating,2017-06-27 08:25:00-04:00,CGIX,negative
234679.0,"Cancer Genetics, Inc. Launches FDA-Approved Universal Companion Diagnostic for Lung Cancer Using Thermo Fisher's Next Generation Sequencing Panel Oncomine Dx Target Test",2017-06-27 07:36:00-04:00,CGIX,negative
234680.0,18 Biggest Mid-Day Gainers For Monday,2017-06-26 12:19:00-04:00,CGIX,neutral
234681.0,"Benzinga's Top Upgrades, Downgrades For June 26, 2017",2017-06-26 09:21:00-04:00,CGIX,positive
234682.0,"Benchmark Initiates Coverage On Cancer Genetics with Speculative Buy Rating, Announces $6.00 Price Target",2017-06-26 07:56:00-04:00,CGIX,negative
234683.0,"Cancer Genetics 10%+ owner Pappajohn Buys 100,000 @ Avg Price: $3.75 -Form4",2017-06-12 16:17:00-04:00,CGIX,negative
234684.0,Streetsweeper Out With Short Report On Cancer Genetics,2017-06-08 12:02:00-04:00,CGIX,negative
234685.0,Cancer Genetics Launches Complete::IO,2017-04-24 07:36:00-04:00,CGIX,negative
234686.0,Cancer Genetics Wins Contract With eFFECTOR Therapeutics for Clinical Biomarket Services,2017-04-10 07:12:00-04:00,CGIX,negative
234687.0,"Cancer Genetics, Inc. and Mendel.ai Report Strategic Partnership Enabling AI To Accelerate Clinical Matching For Cancer Care",2017-04-03 07:03:00-04:00,CGIX,negative
234688.0,15 Biggest Mid-Day Losers For Tuesday,2017-03-28 13:00:00-04:00,CGIX,negative
234689.0,Cancer Genetics Pops to High of $3.60 on Volume,2017-03-24 10:19:00-04:00,CGIX,negative
234690.0,Mid-Afternoon Market Update: Cancer Genetics Gains After Q4 Results; Heat Biologics Shares Slide,2017-03-23 14:32:00-04:00,CGIX,negative
234691.0,15 Biggest Mid-Day Gainers For Thursday,2017-03-23 12:29:00-04:00,CGIX,neutral
234692.0,Mid-Morning Market Update: Markets Mostly Flat; Conagra Profit Beats Estimates,2017-03-23 10:36:00-04:00,CGIX,positive
234693.0,18 Stocks Moving In Thursday's Pre-Market Session,2017-03-23 08:23:00-04:00,CGIX,neutral
234694.0,Cancer Genetics Reports Q4 EPS $(0.15) vs. $(0.22) Est.,2017-03-23 07:32:00-04:00,CGIX,negative
234695.0,"Earnings Scheduled For March 23, 2017",2017-03-23 04:20:00-04:00,CGIX,neutral
234696.0,Cancer Genetics Announces Launch Of A Focused Genomic Panel For Hereditary Breast And Ovarian Cancer,2017-01-25 12:51:00-05:00,CGIX,negative
234697.0,Cancer Genetics Signed 5 Agreements for Development of Liquid Biopsy Tests,2017-01-09 09:30:00-05:00,CGIX,negative
234698.0,"Cancer Genetics, Inc. Is Selected by BeiGene, Ltd. to Partner on Clinical Trial Services & Advance Portfolio of Novel Oncology Therapeutics",2016-12-07 07:54:00-05:00,CGIX,negative
234699.0,12 Biggest Mid-Day Losers For Monday,2016-11-28 13:05:00-05:00,CGIX,negative
234700.0,"Cancer Genetics Reports Q3 EPS $(0.23) vs. Est. $(0.28), Rev. $6.75M vs. Est. $6.93M",2016-11-10 07:26:00-05:00,CGIX,negative
234701.0,Rodman & Renshaw Prescribe A $6 Price Target For Cancer Genetics,2016-09-26 09:10:00-04:00,CGIX,negative
234702.0,"Rodman & Renshaw Initiates Coverage on Cancer Genetics at Buy, Announces $6.00 PT",2016-09-26 07:02:00-04:00,CGIX,negative
234703.0,"Cancer Genetics, Inc. Reports Collaboration with BARC Global Central Laboratory to Offer Comprehensive Clinical Trial and Companion Diagnostic Solutions",2016-09-20 07:30:00-04:00,CGIX,negative
234704.0,Stocks Hitting 52-Week Lows,2016-09-16 10:18:00-04:00,CGIX,negative
234705.0,Cancer Genetics Reports $5.5M Registered Direct Offering,2016-09-09 07:31:00-04:00,CGIX,negative
234706.0,"Cancer Genetics Reports NY State Approval for Focus::Myeloid NGS-Based Panel for AML, MDS, MPN",2016-08-17 07:31:00-04:00,CGIX,positive
234707.0,"Cancer Genetics Reports NY State Approval for Focus::Myeloid NGS-Based Panel for AML, MDS, MPN",2016-08-17 07:31:00-04:00,CGIX,positive
234708.0,"Cancer Genetics Inc. Selected by H3 Biomedicine Inc., to Provide Biomarker Discovery and Testing for a Global Drug Development Program in Hematologic Cancers",2016-07-18 09:30:00-04:00,CGIX,negative
234709.0,Cancer Genetics Reports Received NY State Approval for Focus:CLL,2016-06-30 07:31:00-04:00,CGIX,negative
234710.0,Cancer Genetics Adds VENTANA Assay As Complementary Diagnostic Test For TECENTRIQ,2016-06-29 07:59:00-04:00,CGIX,negative
234711.0,Cancer Genetics Announces Jay Roberts COO and EVP Finance,2016-06-27 07:31:00-04:00,CGIX,negative
234712.0,"Cancer Genetics, Inc. and Sayre Therapeutics Announce Distribution Agreement to Commercialize Tissue of Origin",2016-06-23 08:26:00-04:00,CGIX,negative
234713.0,Sabby Management 6.71% Passive Stake In Cancer Genetics in 13G,2016-05-24 09:55:00-04:00,CGIX,negative
234714.0,Cancer Genetics Reports $5M Registered Direct Offering,2016-05-20 09:01:00-04:00,CGIX,negative
234715.0,Cancer Genetics Expands Market Share In Immuno-Oncology Focused Clinical Studies,2016-05-04 10:13:00-04:00,CGIX,negative
234716.0,Cancer Genetics Reports Significantly Expanded Marketshare in Immuno-Oncology Focused Trials with 12 Active Trials in Progress,2016-05-04 08:37:00-04:00,CGIX,positive
234717.0,"Cancer Genetics, Inc. Significantly Increases Marketshare In Immuno-Oncology Focused Clinical Trials With 12 Active Clinical Trials In Progress",2016-05-04 08:35:00-04:00,CGIX,positive
234718.0,"Chairman Pappajohn Buys 100,000 Shares of Cancer Genetics @$2.53/Share",2016-03-16 16:57:00-04:00,CGIX,negative
234719.0,"Aegis Capital Maintains Buy on Cancer Genetics, Lowers PT to $8.00, Says 'Expect improvement from new test launches and cost synergies'",2016-03-15 15:36:00-04:00,CGIX,negative
234720.0,Janney Capital Downgrades Cancer Genetics to Neutral,2016-03-11 07:54:00-05:00,CGIX,negative
234721.0,"Cancer Genetics Reports Q4 EPS $(0.48) Vs Est $(0.46), Sales $5.5M  Vs Est $7.00M",2016-03-10 15:56:00-05:00,CGIX,negative
234722.0,Cancer Geneetics Launches Immuno-Oncology Testing Portfolio,2016-01-21 08:00:00-05:00,CGIX,negative
234723.0,"Cancer Genetics Reports Q3 EPS ($0.56) Vs Est ($0.49), Sales $4M vs Est $4M",2015-11-10 07:32:00-05:00,CGIX,negative
234724.0,"Empery Asset Management Reports 6.49% Passive Stake In Cancer Genetics as of November 6, 2015",2015-11-10 06:04:00-05:00,CGIX,negative
234725.0,"Filing from Cancer Genetics Shows Offering for 3M Shares of Common Stock, Warrants to Purchase Up to 3M Shares of Common",2015-11-09 09:10:00-05:00,CGIX,negative
234726.0,Cancer Genetics to Report Biomarker Findings in Metastatic Clear Cell Renal Carcinoma Using a CGI-Designed NGS Panel,2015-11-07 20:08:00-05:00,CGIX,negative
234727.0,"Cancer Genetics Prices 3M-Share Underwritten Public Offering at $4/Share, Expects Gross Proceeds From Offering of $12M",2015-11-06 06:53:00-05:00,CGIX,negative
234728.0,"Cancer Genetics Prices 3M Shares of Common at $4/Share, Five-Year Warrants to Buy 3M Shares of Common at $5/Share for Gross Proceeds $12M",2015-11-06 06:45:00-05:00,CGIX,negative
234729.0,Shares of Cancer Genetics Up 16+% Following News Co. Received Third Patent for Proprietary Genomic FHACT Test,2015-10-28 10:36:00-04:00,CGIX,negative
234730.0,SWK Holdings Reports 6.9%t Passive Stake in Cancer Genetics as of October 9,2015-10-19 12:52:00-04:00,CGIX,negative
234731.0,"UPDATE: Cancer Genetics Sees Deal for Response Genetics Adding $4M to Co.'s Future Contract Value from Biopharma, Clinical Research Clients",2015-10-12 08:49:00-04:00,CGIX,negative
234732.0,"Cancer Genetics Reports 90+% of Added $10-$12M in Sales from Response Genetics Deal Related to Molecular Profiling, Therapeut8ic Selection, Patient Monitoring",2015-10-12 08:49:00-04:00,CGIX,negative
234733.0,"8-K from Response Genetics Shows Co. Received Approval from Bankruptcy Court to Sell Substantially All Assets to Cancer Genetics for $14M in Cash, Common Stock",2015-10-05 16:27:00-04:00,CGIX,negative
234734.0,"Cancer Genetics Receives Bankruptcy Court Approval to Purchase Los Angeles-Based Response Genetics, Inc.",2015-10-02 08:00:00-04:00,CGIX,negative
234735.0,"Cancer Genetics, Inc. Increases Access to Proprietary Diagnostics Tests as Part of New Agreement With Blue Cross Blue Shield of Illinois",2015-09-08 07:32:00-04:00,CGIX,negative
234736.0,"Cancer genetics Reports Inline Q2 Loss $0.51, Sales $4.2M vs Est $4.67M",2015-08-11 07:31:00-04:00,CGIX,negative
234737.0,"Response Genetics Reports Entering of Asset Purchase Deal with Cancer Genetics, Will Be Proposed Under Chapter 11 Voluntary Bankruptcy, Says Business Will Be Uninterrupted",2015-08-10 08:53:00-04:00,CGIX,negative
234738.0,"Cancer Genetics, Inc. Reports the Expansion of Access to Its Proprietary Diagnostic Tests Through Agreement With Harvard Pilgrim Healthcare",2015-07-16 07:01:00-04:00,CGIX,negative
234739.0,Filing from Cancer Genetics Shows Registration for $20M Common Stock Offering,2015-07-16 06:22:00-04:00,CGIX,negative
234740.0,US Stock Futures Edge Lower Ahead Of International Trade Data,2015-07-07 07:06:00-04:00,CGIX,negative
234741.0,Cancer Genetics Inc. Announces a Partnership With ICON's Laboratory Services to Offer Comprehensive Oncology Laboratory Testing and Solutions,2015-07-07 07:00:00-04:00,CGIX,negative
234742.0,"Cancer Genetics, Inc. Awarded Largest Clinical Trial in Company History",2015-06-30 07:31:00-04:00,CGIX,negative
234743.0,Cancer Genetics To Announce Kidney Cancer Treatment Study At 2015 ASCO Annual Meeting,2015-05-29 07:33:00-04:00,CGIX,negative
234744.0,Cancer Genetics Selected to Power Next-Generation Sequencing Services for ReproCELL,2015-05-26 07:01:00-04:00,CGIX,negative
234745.0,"Cancer Genetics Selected to Power Next-Generation Sequencing Services for ReproCELL, a Global Regenerative Medicine Market Leader, in a Multi-Year Agreement",2015-05-26 07:00:00-04:00,CGIX,negative
234746.0,Cancer Genetics Names Mandar Kulkarni as Chief Technology Officer,2015-05-22 07:34:00-04:00,CGIX,negative
234747.0,RedChip Issues Research Update on Cancer Genetics,2015-05-18 07:32:00-04:00,CGIX,negative
234748.0,"Cancer Genetics Reports Q1 EPS $(0.44) vs. Est. $(0.54), Rev.$4.37M vs. Est. $4.37M",2015-05-12 07:31:00-04:00,CGIX,negative
234749.0,Cancer Genetics Enters Into Multi-Year Research Collaboration With Moffitt Cancer Center,2015-05-06 07:32:00-04:00,CGIX,negative
234750.0,"Cancer Genetics Expands Sequencing Capabilities in India With Launch of Solid Tumor Hotspot Panel for Biopharma, Clinical Customers Throughout Asia",2015-04-21 07:39:00-04:00,CGIX,negative
234751.0,"Cancer Genetics, Inc. Receives New York State Licensure for FHACT Cervical Cancer Test",2015-04-16 07:46:00-04:00,CGIX,negative
234752.0,"Janney Capital Initiates Coverage on Cancer Genetics at Buy, Announces $13.00 PT",2015-04-09 06:54:00-04:00,CGIX,negative
234753.0,Cancer Genetics Reports Q4 Adj. Loss of $0.49/Share vs Loss of $0.50/Share Est.,2015-03-12 07:33:00-04:00,CGIX,negative
234754.0,"Cancer Genetics Names Randy Goodman, Ph.D., Director of Reimbursement and Clinical Revenue Cycle Management",2015-02-11 07:33:00-05:00,CGIX,negative
234755.0,Cancer Genetics Launches ExpandDx,2015-01-20 07:35:00-05:00,CGIX,negative
234756.0,Cancer Genetics Reports Received Approval for Providing of Oncology Testing for Patients in California,2015-01-05 07:46:00-05:00,CGIX,negative
234757.0,"Cancer Genetics, Inc. Announces Appointment of Venkatadri Bobba to Cancer Genetics India's Board of Directors",2014-12-16 07:31:00-05:00,CGIX,negative
234758.0,"Cancer Genetics Director Pappajohn Buys 39,686 Shares @$5.35/Share -Form 4",2014-12-10 16:27:00-05:00,CGIX,negative
234759.0,"Cancer Genetics Names Rob Fannon as VP of Operations in Raleigh/Research Triangle Park, NC Location",2014-12-10 07:33:00-05:00,CGIX,negative
234760.0,"Cancer Genetics, Inc. to Receive $530,000 Through New Jersey Technology Business Tax Program",2014-12-09 07:30:00-05:00,CGIX,negative
234761.0,Cancer Genetics Inc Receives Second Patent For Genomic Cervical Cancer Test; Strengthens Position Of FHACT,2014-11-11 08:16:00-05:00,CGIX,negative
234762.0,Cancer Genetics Reports Second Patent for Genomic Cervical Cancer Test,2014-11-11 07:56:00-05:00,CGIX,negative
234763.0,Morning Market Movers,2014-11-10 09:43:00-05:00,CGIX,neutral
234764.0,Cancer Genetics Reports Q3 EPS of $(0.41) vs $(0.48) Est; Revenue of $3.22M vs $3.18M Est,2014-11-10 07:56:00-05:00,CGIX,negative
234765.0,Cancer Genetics Reports FHACT(R) Has Received CE Mark,2014-09-02 08:16:00-04:00,CGIX,negative
234766.0,Morning Market Movers ,2014-08-27 09:39:00-04:00,CGIX,neutral
234767.0,Cancer Genetics Proproetary Genomic Tests Added To Nat'l Institutes of Genetic Testing Registry,2014-08-27 08:05:00-04:00,CGIX,negative
234768.0,Cancer Genetics Reports Q2 EPS of $(0.50) vs $(0.37) Est,2014-08-14 07:07:00-04:00,CGIX,negative
234769.0,"Cancer Genetics, Inc. Releases The Only Comprehensive Genomic Test To Diagnose & Stratify The Most Common Form of Leukemia (CLL)",2014-08-04 07:32:00-04:00,CGIX,negative
234770.0,"Cancer Genetics Announces Acquisition Of Gentris Corporation, A Leading Global Pharmacogenomics Company, And Increases Contract Backlog To Over $18 Million",2014-07-21 07:47:00-04:00,CGIX,negative
234771.0,Cancer Genetics Announces Acquisition of Gentris Corporation For $4.75M,2014-06-23 08:39:00-04:00,CGIX,negative
234772.0,"Cancer Genetics Reports Partnership with AstraZeneca for Providing Biomarker, Molecular Based Testing",2014-06-09 08:01:00-04:00,CGIX,negative
234773.0,Cancer Genetics Files $100M Mixed Securities Shelf,2014-05-29 17:06:00-04:00,CGIX,negative
234774.0,Actinium Set To Follow In Opko's Foosteps Amid Near Term Catalysts,2014-05-27 07:27:00-04:00,CGIX,neutral
234775.0,Cancer Genetics Reports Q1 EPS of $(0.27) vs $(0.29) Est; Revenue of $1.43M vs $2.17M Est,2014-05-15 08:15:00-04:00,CGIX,negative
234776.0,Cancer Genetics to Acquire BioServe India For $1.9M,2014-05-15 08:13:00-04:00,CGIX,negative
234777.0,"Cantor Fitzgerald Initiates Coverage on Cancer Genetics at Buy, Announces $21.00 PT",2014-04-01 08:59:00-04:00,CGIX,negative
234778.0,Cancer Genetics Reports Q4 EPS of $(0.37) vs $(0.36) Est; Revenue of $1.90M vs $1.95M Est,2014-03-26 16:04:00-04:00,CGIX,negative
234779.0,Cancer Genetic's Proprietary DNA-Based Test For Cervical Cancer Adopted By Kamineni Hospital Group In India,2014-03-20 08:05:00-04:00,CGIX,negative
234780.0,Cancer Genetics Names Edward Sitar as CFO,2014-03-17 08:01:00-04:00,CGIX,negative
234781.0,Cancer Genetics Announces Additional Kidney Cancer Patent ,2014-02-26 07:32:00-05:00,CGIX,negative
234782.0,"Cancer Genetics, Roche Announce Expanded, Exclusive International Agreement to Provide Molecular Diagnostic Cancer Testing ",2014-02-10 07:01:00-05:00,CGIX,negative
234783.0,Cancer Genetics Names John Pappajohn Chairman of the Board of Directors ,2014-01-06 07:01:00-05:00,CGIX,negative
234784.0,Cancer Genetics Says Recently Invested $1M in Oncospire,2013-11-22 08:32:00-05:00,CGIX,negative
234785.0,Cancer Genetics Launches Proprietary DNA-Based Cervical Cancer Diagnostic Test in US,2013-11-18 08:16:00-05:00,CGIX,negative
234786.0,UPDATE: Aegis Capital Reiterates on Cancer Genetics Following Better-Than-Expected 3Q 2013 Financial Results,2013-11-14 11:36:00-05:00,CGIX,negative
234787.0,Cancer Genetics Reports Q3 EPS of $(0.61) vs $(0.71) Est; Revenue of $1.71M vs $1.60M Est,2013-11-13 16:07:00-05:00,CGIX,negative
234788.0,"Cancer Genetics Reports Full Exercise of Over Allotment Option for Added 428,700 Shares at $14/Share, for Total Gross Proceeds $46M",2013-10-24 18:21:00-04:00,CGIX,negative
234789.0,"Cancer Genetics Prices 2.858M Shares at $14/Share, Expecting Proceeds of $40M",2013-10-22 18:14:00-04:00,CGIX,negative
234790.0,Cancer Genetics Shares Rally As Feltl Analyst Getting More Bullish,2013-10-02 11:01:00-04:00,CGIX,negative
234791.0,Benzinga's Volume Movers,2013-10-02 10:26:00-04:00,CGIX,neutral
234792.0,Hearing Feltl Raises PT on Cancer Genetics to $30,2013-10-02 09:55:00-04:00,CGIX,negative
234793.0,"Aegis Capital Initiates Coverage on Cancer Genetics at Buy, Announces $25.00 PT",2013-09-26 10:10:00-04:00,CGIX,negative
234794.0,Cancer Genetics Prices 1.5M Share Offering at $10.00/Share ,2013-08-13 20:10:00-04:00,CGIX,negative
234795.0,Cancer Genetics Reports Q2 EPS of $(2.29) Which May Not Compare $(0.53) Est,2013-08-05 07:38:00-04:00,CGIX,negative
234796.0,"Feltl & Co. Initiates Coverage on Cancer Genetics at Strong Buy, Announces $17.50 PT",2013-05-21 10:06:00-04:00,CGIX,negative
234797.0,"Cancer Genetics Revises Terms for IPO: Lowered Share Amount from 5M to 1.85M Shares, Boosted Price Range from Initial $4-6 to $10-12/Share",2013-03-04 10:41:00-05:00,CGIX,neutral
